Three-component non-invasive risk score for undiagnosed diabetes in Chinese people: Development, validation and longitudinal evaluation

被引:11
作者
Woo, Yu Cho [1 ]
Gao, Bin [2 ]
Lee, Chi Ho [1 ]
Fong, Carol Ho-yi [1 ]
Lui, David Tak-wai [1 ]
Ming, Jie [2 ]
Wang, Li [2 ]
Yeung, Kristy Man-yi [1 ]
Cheung, Bernard Man-yung [1 ]
Lam, Tai Hing [3 ]
Janus, Edward [4 ,5 ]
Ji, Qiuhe [2 ]
Lam, Karen Siu-ling [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China
[2] Air Force Med Univ, Xijing Hosp, Dept Endocrinol, Xian, Shaanxi, Peoples R China
[3] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China
[4] Univ Melbourne, Melbourne Med Sch, Dept Med Western Hlth, St Albans, Vic, Australia
[5] Western Hlth, Gen Internal Med Unit, St Albans, Vic, Australia
关键词
Diabetes; Non-invasive; Score; LIFE-STYLE INTERVENTION; FOLLOW-UP; TYPE-2; COMPLICATIONS; POPULATION; PREVALENCE; DIAGNOSIS; CRITERIA; ASSOCIATION; STRATEGIES;
D O I
10.1111/jdi.13144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Introduction To develop a new non-invasive risk score for undiagnosed diabetes in Chinese people, and to evaluate the incident diabetes risk in those with high-risk scores, but no diabetes on initial testing. Materials and Methods A total of 2,609 participants with no known diabetes (aged 25-74 years) who underwent oral glucose tolerance tests in Hong Kong (HK) were investigated for independent risk factors of diabetes to develop a categorization point scoring system, the Non-invasive Diabetes Score (NDS). This NDS was validated in a cross-sectional study of 2,746 participants in Shaanxi, China. HK participants tested to not have diabetes at baseline were assessed for subsequent incident diabetes rates. Results In the HK cohort, hypertension, age and body mass index were the key independent risk factors selected to develop the NDS, with >= 28 out of 50 NDS points considered as high risk. The area under the receiver operating characteristic curve for undiagnosed diabetes was 0.818 and 0.720 for the HK and Shaanxi cohort, respectively. The negative predictive value was 97.4% (HK) and 95.8% (Shaanxi); the number needed to screen to identify one case of diabetes was five (HK) and 11 (Shaanxi), respectively. Among those that tested non-diabetes at baseline, individuals with NDS >= 28 had a threefold risk of incident diabetes during the subsequent 20.9 years, compared with those with NDS <28 (P < 0.001), with a steeper rise in incident diabetes observed in those with NDS at higher tertiles. Conclusions This new three-component risk score is a user-friendly tool for diabetes screening, and might inform the subsequent testing interval for high-risk non-diabetes individuals.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 36 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
[Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]
[5]   Development and Validation of a Patient Self-assessment Score for Diabetes Risk [J].
Bang, Heejung ;
Edwards, Alison M. ;
Bomback, Andrew S. ;
Ballantyne, Christie M. ;
Brillon, David ;
Callahan, Mark A. ;
Teutsch, Steven M. ;
Mushlin, Alvin I. ;
Kern, Lisa M. .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (11) :775-W255
[6]   Association between raised blood pressure and dysglycemia in Hong Kong Chinese [J].
Cheung, Bernard M. Y. ;
Wat, Nelson M. S. ;
Tso, Annette W. K. ;
Tam, Sidney ;
Thomas, G. Niel ;
Leung, Gabriel M. ;
Tse, Hung Fat ;
Woo, Jean ;
Janus, Edward D. ;
Lau, Chu Pak ;
Lam, Tai Hing ;
Lam, Karen S. L. .
DIABETES CARE, 2008, 31 (09) :1889-1891
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting [J].
Collins, Gary S. ;
Mallett, Susan ;
Omar, Omar ;
Yu, Ly-Mee .
BMC MEDICINE, 2011, 9
[9]   Cardiovascular Disease Risk Assessment: Insights from Framingham [J].
D'Agostino, Ralph B. ;
Pencina, Michael J. ;
Massaro, Joseph M. ;
Coady, Sean .
GLOBAL HEART, 2013, 8 (01) :11-23
[10]   How diabetes risk assessment tools are implemented in practice: A systematic review [J].
Dhippayom, Teerapon ;
Chaiyakunapruk, Nathorn ;
Krass, Ines .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) :329-342